Amazing big spikes
Release time:
2020-08-14
Great Big Peak
In the group's QQ group and WeChat group, I often see colleagues with titles such as "Daye Peak" and "Tianjin Peak" in front of their names communicate with each other, but at that time I didn't think carefully about how these brothers and sisters from all over the world and such a large team come together. In this economy, it is not very prosperous, in the era of fierce market competition, what kind of great enterprise should the peak be able to fight north and south like a broken bamboo and keep moving forward? It is a great honor that I am also a member of the big family of Jianfeng. What's more, on the 8th birthday of Jianfeng 60#, I can fly over Qian Shan Wanshui from Pu'er, Yunnan Province, to the headquarters and celebrate with colleagues from other places! Before
arrived at the group headquarters, the peak building was seen standing solemnly by the Jinhua river from a distance. Stepping into the gate of the peak building, I feel like I have returned to my home that I have been away for a long time. I am strange but familiar, and I am inexplicably excited. In the exhibition hall of the group company, editor-in-chief fu of the peak newspaper told us about the growth of peak 60 .
The first thing that caught our attention was, of course, the development of the spike. 1958 , when we were not yet born, our ancestors came to the wise temple east of qianzhuangtou village in anshi township (now luodian town), kilometers north of Jinhua city. with a pair of hands and passion, they built Jinhua's first cement factory on the desolate hillside of 16.94 mu and began the process of hard work. The pictures of "cattle pulling into a ball" and "barrel into a ball" on the display board not only show the backward technology and the difficult conditions at that time, but also reflect the drive in the bones of the ancestors and their determination to win. Seeing these pictures, my heart is full of admiration, sincerely admire the ancestors of the peak, and planted this evergreen tree for us latecomers!
Next is a panorama of the Jinhua cement plant. Editor-in-chief fu told us that during the period from 1984 to , under the new situation of national reform and opening up, Jinhua cement factory held high the banner of reform, improved various basic management systems, adjusted and strengthened the leading group, broke the boundary of ownership through horizontal alliance with township enterprises, realized the first leap in enterprise development, expanded the scale of the enterprise rapidly, and formed a cement group, the successful transformation of the shareholding system has accumulated energy for the take-off of the enterprise. Next to it is also displayed the first stock issued after the implementation of the shareholding system. Although we didn't feel the joy and benefit that the stock brought to the peak people at that time, but looking at these, our hearts are also extremely proud and proud! The pictures in the
exhibition hall let us feel the twists and turns of the development of the peak, and also let us know more about the brother enterprises in the peak family. For example, Jianfeng Pharmaceutical, which we have never come into contact with before, is a comprehensive pharmaceutical enterprise integrating science, industry and trade, with the development, production and operation of various chemical source drugs and preparations, proprietary Chinese medicines, and biological preparations as its main business. it is a national high-tech enterprise, a national-level industrialization project demonstration enterprise, and one of the top 100 pharmaceutical enterprises in China. In line with the enterprise spirit of "establishing peak ambition and making high-quality medicine", Jianfeng Pharmaceutical Company pursues the business philosophy of "science and technology to create health" and "innovation to enhance medicine". Focus on developing new products with high added value, high-tech content and independent intellectual property rights, and implement the "going out" strategy, participate in international competition, open up new markets, and strive to cultivate Jianfeng Pharmaceutical into a strong scale and strength, and there is a higher level of profitability of the new enterprise ...... Hearing this, our hearts surged with ambition.
60 years of development, the peak from a small state-owned factory, grew into a comprehensive modern joint-stock enterprise, and formed its own unique corporate culture. Through thinking innovation, technological innovation, management innovation, and mechanism innovation, the peak keeps the company vigorous and vigorous in the continuous change; through the formulation of practical development strategies, continuous strengthening of execution and risk avoidance capabilities, our company has achieved A healthy and stable development; through the establishment of a modern enterprise system, effective democratic management, system construction and scientific management of enterprises, our spikes are full of vitality. Moreover, while making great contributions to the local economy, Jianfeng also strives to repay the society, actively undertakes social responsibilities, loves charity and public welfare undertakings, helps the poor and the needy, donates money to schools, and promotes social harmony and prosperity... Seeing these, I think of our Yunnan Jianfeng. Although it has been put into production for only a short period of 5 years, we have worked hard to spend every day and night in every ordinary post, every love we give to the people in the disaster areas, and every bit of support we give to the poor villages, do not fully prove all this? In the exhibition hall
, there is a sentence that is particularly impressive, "We are committed to being a respected company and an admired company". Now, the photo of this sentence is stored in my mobile phone. Every time I see this sentence, I will urge me to work hard. I believe that on the road to the "Centennial Peak" in the future, we, the peak people from all over the world, will unite as one and build together! (Luo Meiyan)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page